OFW
UTHR icon

Omnia Family Wealth’s United Therapeutics UTHR Stock Holding History

Omnia Family Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8
Closed -$1K – 500
2019
Q1 		$1K Hold
8
– – ﹤0.01% 567
2018
Q4 		$1K Hold
8
– – ﹤0.01% 537
2018
Q3 		$1K Hold
8
– – ﹤0.01% 561
2018
Q2 		$1K Hold
8
– – ﹤0.01% 543
2018
Q1 		$1K Hold
8
– – ﹤0.01% 577
2017
Q4 		$1K Hold
8
– – ﹤0.01% 584
2017
Q3 		$1K Hold
8
– – ﹤0.01% 598
2017
Q2 		$1K Hold
8
– – ﹤0.01% 685
2017
Q1 		$1K Hold
8
– – ﹤0.01% 688
2016
Q4 		$1K Buy
+8
New +$1.02K ﹤0.01% 712

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Omnia Family Wealth's UTHR Position: Q2 2019 in Review

Omnia Family Wealth sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 8 shares — an estimated $1K sold.

Omnia Family Wealth first reported a position in UTHR in Q4 2016 and held it in 10 quarters. The position peaked at $1K in Q1 2019. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • Omnia Family Wealth reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Omnia Family Wealth sold 8 United Therapeutics shares in Q2 2019, an estimated $1K.
  • Omnia Family Wealth first reported a position in United Therapeutics in Q4 2016 and held it in 10 quarters.
  • Omnia Family Wealth's United Therapeutics position peaked at $1K in Q1 2019.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on Omnia Family Wealth's 13F filing for Q2 2019, filed 7 Aug 2019.